Selected medical management of the older rehabilitative patient

Archives of Physical Medicine and Rehabilitation

Volumn 85, Issue SUPPL. 3, 2004, Pages 76-82

  Lin, John L ^a,b   Armour, Doris ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Aged; Diabetes mellitus; Drug therapy; Hypertension; Rehabilitation; Sleep disorders; Urinary tract infections

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; AMOXICILLIN; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORAL HYDRATE; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTAZOLAM; HYPNOTIC AGENT; INSULIN; LORAZEPAM; METFORMIN; NEFAZODONE; SEDATIVE AGENT; SULFONYLUREA DERIVATIVE; TEMAZEPAM; TRAZODONE; ZALEPLON; ZOLPIDEM;

AGED; AGING; BEHAVIOR MODIFICATION; CARDIOTOXICITY; CLOSED ANGLE GLAUCOMA; CONSTIPATION; DIABETES MELLITUS; DISEASE CONTROL; GERIATRIC CARE; GERIATRIC DISORDER; GERIATRICS; HUMAN; HYPERCALCEMIA; HYPERTENSION; INSOMNIA; LIFESTYLE; ORTHOSTATIC HYPOTENSION; PHYSICAL MEDICINE; POLYPHARMACY; PRESCRIPTION; REHABILITATION MEDICINE; REVIEW; SLEEP DISORDER; TREATMENT CONTRAINDICATION; URINARY TRACT INFECTION; URINE RETENTION;

EID: 3042550894     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2004.04.015     Document Type: Article

References (101)

1. Strasser D.C., Solomon D.H., Burton J.R. Geriatrics and physical medicine and rehabilitation common principles, complementary approaches, and 21st century demographics. Arch Phys Med Rehabil. 83:2002;1323-1324
2. American Association of Retired Persons, Administration on Aging, US Department of Health and Human Services. A profile of older Americans 1999. 1999;AARP, Washington (DC)
3. Cifu D.X., Means K.M., Currie D.M., Gershkoff A.M. Geriatric rehabilitation. 2. Diagnosis and management of acquired disabling disorders. Arch Phys Med Rehabil. 74:(5-S):1993;S406-S412
4. Katz P.R., Grossberg G.T., Potter J.F., et al. Geriatrics syllabus for specialists. 2002;American Geriatrics Society, New York
5. Chutka D.S., Evans J.M., Fleming K.C., Mikkelson K.G. Symposium on geriatrics. Part I. Drug prescribing for elderly patients. Mayo Clin Proc. 70:1995;685-693
6. Fulop T. Jr, Worum I., Csongor J., Foris G., Leovey A. Body composition in elderly people. I. Determination of body composition by multiisotope method and the elimination kinetics of these isotopes in healthy elderly subjects. Gerontology. 31:1985;6-14
7. Beyth R.J., Shorr R.I. Principles of drug therapy in older patients rational drug prescribing. Clin Geriatr Med. 18:2002;577-592
8. Luisi A.F., Owens N.J., Hume A.L. Drugs and the elderly. Gallo J.J., Reichel W. Reichel's care of the elderly clinical aspects of aging. 5th ed. 1999;59-87 Lippincott Williams & Wilkins, Philadelphia
9. Campion E.W., deLabry L.O., Glynn R.J. The effect of age on serum albumin in healthy males report from the Normative Aging Study. J Gerontol. 43:1988;M18-M20
10. Nolan L., O'Malley K. Prescribing for the elderly. Part I. Sensitivity of the elderly to adverse drug reactions. J Am Geriatric Soc. 36:1988;142-149
11. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States the Slone survey. JAMA. 287:2002;337-344
12. Hale W.E., May F.E., Marks R.G., Stewart R.B. Drug use in an ambulatory elderly population a five-year update. Drug Intell Clin Pharm. 21:1987;530-535
13. Podrazik P.M., Schwarts J.B. Cardiovascular pharmacology of aging. Cardiol Clin. 17:1999;17-34
14. Graves T., Hanlon J.T., Schmader K.E., et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med. 157:1997;2205-2210
15. Vaes L.P., Chyka P.A. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng nature of the evidence. Ann Pharmacother. 34:2000;1478-1482
16. Smolinske S.C. Dietary supplement-drug interactions. J Am Med Womens Assoc. 54:1999;191-192. 195
17. Black D.M., Brand R.J., Greenlick M., Hughes G., Smith J. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. Systolic Hypertension in the Elderly Program. J Gerontol. 42:1987;552-557
18. Collet J.P., Boivin J.F., Spitzer W.O. Bias and confounding in pharmacoepidemiology. Strom B.L. Pharmacoepidemiology. 2nd ed. 1994;609-627 John Wiley & Sons, Chichester
19. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 289:2003;2560-2572
20. Mukai S., Lipsitz L.A. Orthostatic hypotension. Clin Geriatr Med. 18:2002;253-268
21. Auseon A., Ooi W.L., Hossain M., Lipsitz L.A. Blood pressure behavior in the nursing home implications for diagnosis and treatment of hypertension. J Am Geriatr Soc. 47:1999;285-290
22. Izzo J.L. Jr, Shykoff B.E. Arterial stiffness clinical relevance, measurement, and treatment. Rev Cardiovasc Med. 2:2001;29-34. 37-40
23. Cheng K.S., Baker C.R., Hamilton G., Hoeks A.P., Seifalian A.M. Arterial elastic properties and cardiovascular risk/event. Eur J Vasc Endovasc Surg. 24:2002;383-397
24. Collins K.J., Exton-Smith A.N., James M.H., Oliver D.J. Functional changes in autonomic nervous responses with ageing. Age Ageing. 9:1980;17
25. Rutan G.H., Hermanson B., Bild D.E., LaBaw F., Tell G.S. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 19:1992;508-519
26. Luukinen H., Koski K., Laippala P., Kivela S.L. Prognosis of diastolic and systolic orthostatic hypotension in older persons. Arch Intern Med. 159:1999;273-280
27. Weinberger J. Contemporary diagnosis and management of stroke. 2nd ed. 2000;111 Handbooks in Health Care, Newtown (PA)
28. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 288:2002;2981-2997
29. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Committee on the Management of Patients with Unstable Angina. J Am Coll Cardiol. 40:2002;1366-1374
30. Drakos S.G., Anastasiou-Nana M.I., Nanas J.N. Exacerbation of variant angina by metoprolol resulting in syncope due to transient atrioventricular block. Int J Cardiol. 82:2002;83-85
31. Salpeter S.R., Ormiston T.M., Salpeter E.E. Cardioselective beta-blockers in patients with reactive airway disease a meta-analysis. Ann Intern Med. 137:2002;715-725
32. Ko D.T., Hebert P.R., Coffey C.S., Sedrakyan A., Curtis J.P., Krumholz H.M. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 288:2002;351-357
33. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 329:1993;1456-1462. [published erratum in: N Engl J Med 1993;330:152]
34. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 345:2001;861-869
35. Mudiyala R., Ahmed A. Effect of terazosin on clinical benign prostatic hyperplasia in older adults. J Am Geriatr Soc. 51:2003;424-426
36. Bassotti G., Calcara C., Annese V., Fiorella S., Roselli P., Morelli A. Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers. Dis Colon Rectum. 41:1998;377-380
37. Andresdottir M.B., van Hamersvelt H.W., van Helden M.J., van de Bosch W.J., Valk I.M., Huysmans F.T. Ankle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine a single-centre study. J Cardiovasc Pharmacol. 35:(3 Suppl 1):2000;S25-S30
38. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. Randomized Aldactone Evaluation Study (RALES). Am J Cardiol. 78:1996;902-907
39. Liou H.H., Huang T.P., Campese V.M. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Nephron. 69:1995;41-48
40. Siscovick D.S., Raghunathan T.E., Psaty B.M., et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 330:1994;1852-1857
41. Siegel D., Hulley S.B., Black D.M., et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 267:1992;1083-1089
42. Resnick H.E., Harris M.I., Brock D.B., Harris T.B. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles results from the Third National Health and Nutrition Examination Survey. Diabetes Care. 23:2000;176-180
43. Crandall J., Barzilai N. Treatment of diabetes mellitus in older people oral therapy options. J Am Geriatr Soc. 51:2003;272-274
44. Gavard J.A., Lustman P.J., Clouse R.E. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care. 16:1993;1167-1178
45. Gregg E.W., Yaffe K., Cauley J.A., et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med. 160:2000;174-180
46. Brown J.S., Seeley D.G., Fong J., Black D.M., Ensrud K.E., Grady D. Urinary incontinence in older women. Who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol. 87:1996;715-721
47. Schwartz A.V., Sellmeyer D.E., Ensrud K.E., et al. Older women with diabetes have an increased risk of fracture a prospective study. J Clin Endocrinol Metab. 86:2001;32-38
48. Greene D.A., Stevens M.J., Feldman E.L. Diabetic neuropathy scope of the syndrome. Am J Med. 107:1999;2S-8S
49. Brown A.F., Mangione C.M., Saliba D., Sarkisian C.A. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 51:(5 Suppl Guidelines):2003;S265-S280
50. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853. [published erratum in: Lancet 1999;354:602]
51. Agurs-Collins T.D., Kumanyika S.K., Ten Have T.R., Adams-Campbell L.L. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects. Diabetes Care. 20:1997;1503-1511
52. Paice B.J., Paterson K.R., Lawson D.H. Undesired effects of the sulfonylurea drugs. Adverse Drug React Acute Poisoning Rev. 4:1985;23-36
53. 2003 physicians' desk reference. Medical Economics. 57th ed. 2003;Thomson, Montvale
54. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N Engl J Med. 346:2002;393-403
55. Harpaz D., Gottlieb S., Graff E., Boyko V., Kishon Y., Behar S. Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group. Am J Med. 105:1998;494-499
56. Haire-Joshu D., Glasgow R.E., Tibbs T.L. Smoking and diabetes. American Diabetes Association. Diabetes Care. 25:(Suppl 1):2002;S89-S90
57. Schrier R.W., Estacio R.O., Esler A., Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 61:2002;1086-1097
58. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 345:2001;861-869
59. Lewis E.J., Hunsicker L.G., Clarke W.R., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 345:2001;851-860
60. Parving H.H., Leh H., Brocchner-Mortensen J., et al. The effect of ibesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 345:2001;870-878
61. Mouton C.P., Bazaldua O.V., Pierce B., Espino D.V. Common infections in older adults. Am Fam Physician. 63:2001;257-268
62. Yoshikawa T.T., Nicolle L.E., Norman D.C. Management of complicated urinary tract infection in older patients. J Am Geriatr Soc. 44:1996;1235-1241
63. Stalam M., Kaye D. Antibacterial therapy antibiotic agents in the elderly. Infect Dis Clin North Am. 14:2000;357-369
64. Nicolle L.E. Urinary tract infections in long-term care facilities. Infect Control Hosp Epidemiol. 14:1993;220-225
65. Berman P., Hogan D.B., Fox R.A. The atypical presentation of infection in old age. Age Ageing. 16:1987;201-207
66. Nicolle L.E. Urinary tract infections asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 11:1997;647-662
67. Yoshikawa T.T. Ambulatory management of common infections in elderly patients. Infect Med. 20:1991;37-43
68. Zhanel G.G., Harding G.K., Guay D.R. Asymptomatic bacteriuria. Which patients should be treated? Arch Intern Med. 150:1990;1389-1396
69. Nicolle L.E., Mayhew J.W., Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med. 83:1987;27-33
70. Ouslander J.G., Schapira M., Schnelle J.F., et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med. 122:1995;749-754
71. Nicolle L.E., Mayhew J.W., Bryan L. Outcome following antimicrobial therapy in an institution. Age Ageing. 17:1988;187-192
72. Bentley D.W., Bradley S., High K., et al. Practice guideline for evaluation of fever and infection in long-term care facilities. Clin Infect Dis. 31:2000;640-653
73. Monane M., Gurwitz J.H., Lipsitz L.A., Glynn R.J., Choodnovskiy I., Avorn J. Epidemiologic and diagnostic aspects of bacteriuria a longitudinal study in older women. J Am Geriatr Soc. 43:1995;618-622
74. Nicolle L.E., Bjornson J., Harding G.K., MacDonell J.A. Bacteriuria in the elderly institutionalized men. N Engl J Med. 309:1983;1420-1425
75. Gupta K., Scholes D., Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 281:1999;736-738
76. Johnson J.R., Stamm W.E. Urinary tract infections in women diagnosis and treatment. Ann Intern Med. 111:1989;906-917
77. Lipsky B.A. Urinary tract infections in men epidemiology, pathophysiology, diagnosis and treatment. Ann Intern Med. 110:1989;138-150
78. McCue J.D. Treatment of urinary tract infections in long-term care facilities advice, guidelines and algorithms. Clin Geriatr. 1999;11-17. (Suppl)
79. Feinsilver S.H. Sleep in the elderly. What is normal? Clin Geriatr Med. 19:2003;177-188. viii
80. American Sleep Disorders Association. International classification of sleep disorders. Diagnostic and coding manual - revised. 1997;ASDA, Rochester (MN)
81. US Public Health Service. Clinician's handbook of preventive services put prevention into practice. 2nd ed. 1998;390 International Medical Publishing, McLean (VA)
82. Foley D.J., Monjan A.A., Brown S.L., Simonsick E.M., Wallace R.B., Blazer D.G. Sleep complaints among elderly persons an epidemiologic study of three communities. Sleep. 18:1995;425-432
83. Straand J., Rokstad K. General practitioners' prescribing patterns of benzodiazepine hypnotics are elderly patients at particular risk for overprescribing? A report from the More & Romsdal Prescription Study. Scand J Prim Health. 15:1997;16-21
84. Bliwise D.L., King A.C., Harris R.B., Haskell W.L. Prevalence of self-reported poor sleep in a healthy population aged 50-65. Soc Sci Med. 34:1992;49-55
85. Manngold J., Lesho E. Insomnia in elders. Federal Practitioner. 19:2002;10-16
86. Ballinger C.B. Subjective sleep disturbance at the menopause. J Psychosom Res. 20:1976;509-513
87. Ancoli-Israel S., Parker L., Sinaee R., Fell R.L., Kripke D.F. Sleep fragmentation in patients from a nursing home. J Gerontol. 44:1989;M18-M21
88. Shigeta H., Yasui A., Nimura Y., et al. Postoperative delirium and melatonin levels in elderly patients. Am J Surg. 182:2001;449-454
89. Tinetti M.E., Speechley M., Ginter S.F. Risk factors for falls among elderly persons living in the community. N Engl J Med. 319:1988;1701-1707
90. King A.C., Oman R.F., Brassington G.S., Bliwise D.L., Haskell W.L. Moderate-intensity exercise and self-rated quality of sleep in older adults a randomized controlled trial. JAMA. 277:1997;32-37
91. Campbell S.S., Dawson D., Anderson M.W. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc. 41:1993;829-836
92. Friedman L., Bliwise D.L., Yesavage J.A., Salom S.R. A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. J Gerontol. 46:1991;P1-P8
93. Morin C.M., Colecchi C., Stone J., Brink D. Behavioral and pharmacological therapies for late-life insomnia a randomized controlled trial. JAMA. 281:1999;991-999
94. Roehrs T., Roth T. Hypnotics efficacy and adverse effects. Kryger M.H., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd ed. 2000;414-418 WB Saunders, Philadelphia
95. Reuben D.B., Herr K., Pacala J.T., Potter J.F., Semla T.P., Small G.W. Geriatrics at your fingertips. 2001;American Geriatrics Society, New York
96. Roth T., Roehrs T.A. Issues in the use of benzodiazepine therapy. J Clin Psychiatry. 53:(Suppl):1992;14-18
97. Greenblatt D.J., Harmatz J.S., Shapiro L., Engelhardt N., Gouthro T.A., Shader R.I. Sensitivity to triazolam in elderly. N Engl J Med. 324:1991;1691-1698
98. Roehrs T., Vogel G., Roth T. Rebound insomnia its determinants and significance. Am J Med. 88:1990;39S-42S
99. Benca R.M. Mood disorders. Kryger M.H., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd ed. 2000;1140-1158 WB Saunders, Philadelphia
100. Trenkwalder C., Walters A.S., Hening W. Periodic limb movements and restless leg syndrome. Neurol Clin. 14:1996;629-650
101. Reuben D.B., Herr K., Pacala J.T., Pollock B.G., Potter J.F., Semla T.P. Geriatrics at your fingertips. 6th ed. 2004;Blackwell Publishing, Malden